How do you pay?

How to pay the least

Cash price

$5,110+ for 30 capsules

Pharmacies pay about this for Nuplazid; you’d pay more.

  1. Ask your pharmacy for Nuplazid’s cash price, and one or two other pharmacies too.
  2. Nuplazid’s savings card works only with insurance from a job or one you bought.

The FDA has approved a generic, but it isn’t in pharmacies yet.

Compare every option

Question
Brand nameNuplazid
Authorized genericpimavanserin
Regular genericpimavanserin
What you’d pay
At least$5,110for 30 capsules; pharmacies pay this
Not soldThere isn’t one
Not soldNot in stores yet
Same as Nuplazid?
The original
–
–

Brand nameThe maker’s card

Acadia Connect Commercial Copay Program

Savings card from Acadia Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on acadiaconnect.com 

Or call 1-844-737-2223. See the offer on acadiaconnect.com

In the maker’s words

“Through the Acadia Connect® Commercial Copay Program, eligible commercially insured patients may pay as little as $0 per month.”

From the maker’s offer on acadiaconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Nuplazid itself, from the same company, sold without the brand name, and usually for less. For now Nuplazid is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

The FDA has approved a generic, but it isn’t in pharmacies yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

Source: the FDA label for Nuplazid (Acadia Pharmaceuticals Inc.), June 18, 2026. Full label on DailyMed 

Good to know